Biotech RadarJobs updated

COMPANY

SignalRX Pharmaceuticals, Inc.

HQ: Cumming, GA source · signalrx.com ↗

Past trials only

Location: Cumming, GA · source · May 3, 2023

Profile checked Oct 10, 2026

Keywords: Advanced Hepatocellular Carcinoma SF1126

1Trials (company is sponsor)

Timeline

  1. Trial start 1: Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT03059147Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma1TerminatedMar 27, 2017Apr 22, 2019 (actual)
Feedback